• Avicenna Alliance continues to grow by welcoming ETEM Biotech among its members

    The latest company to join Avicenna Alliance is ETEM Biotech.

    FIND OUT MORE

  • The Avicenna Alliance discussed upcoming activities

    The Avicenna Alliance board was convened by Secretary General Thierry Marchal on 23 March where board members around the world discussed the activities of the Alliance.

    FIND OUT MORE

  • Avicenna Alliance founding Sec Gen leaves legacy of policy success

    As the Avicenna Alliance enters its 3rd year of operation in 2018, it brings with it a change in management and a huge upscaling of activities.

    FIND OUT MORE

Avicenna Alliance sent letter to Australian Minister Andrews

On 28 October, the Avicenna Alliance sent a letter to the Australian Minister for Industry, Science and Technology Karen Andrews MP asking...

find out more ›

Exploristics joins the Avicenna Alliance

The Avicenna Alliance is proud to announce the newest addition to its list of members: Exploristics. Based in Belfast, Exploristics provide world-class...

find out more ›

Avicenna present at the European Research & Innovation Days

The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses,...

find out more ›

SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the...

find out more ›

Avicenna answers online consultation to shape Horizon Europe

On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework...

find out more ›

Prestigious FDA award allocated to group that developed the V&V 40 standard

The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group...

find out more ›

Dassault Systèmes signs Research Agreement with the FDA

Dassault Systèmes and the U.S. Food and Drug Administration have concluded a five-year extension of their collaboration on the 3DEXPERIENCE...

find out more ›

Sign up for our monthly newsletter!


Sign up